Leverage upon our RExo-System exosomal protein technology to identify the right cohort of patients for your clinical study to minimize time required for clinical trial and maximize your approval.
Top expertise
Currently we have expertise in breast cancer, check-point immunotherapeutic targets (PD-L1/PD-1), colorectal cancer, liver cancer, lung cancer, and Alzheimer.
Free sample tests available!
IVD Companies
Our licensing
Our licensing program is extremely competitive tailored to meet most of your IVD needs.
Custom tailored
Let us custom-design an exosomal protein assay just for your needs!